Search
CELL BANK Website

Back Back
Cell No. : Cell Name
RCB1894 : TE-1  update : 2022/07/22
CommentHuman cell line derived from esophageal cancer. Squamous cell carcinoma. TKG0252 (Deposited from Tohoku Univ.).
Comment from the depositor
Terms and conditions1) In publishing the research results to be obtained by use of this cell line, an acknowledgment to the Depositor, Dr. Tetsuro Nishihira is required. 2) There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC.
Remarks
Order Form Order Form(C-0005.pdf)   MTA(C-0007.pdf)   MTA(C-0007p.pdf)  
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
Basic information Depositor Obinata, Masuo
Originator Nishihira, Tetsuro
Year of deposit 2004
Original cell TKG0252
Animal human < Mammals
Genus Homo
Species sapiens
Gender Male
Tissue esophagus
Classification cancer
History Cell Resource Center for Biomedical Research, Tohoku University(TKG0252)
Lifespan infinite
Morphology epithelial-like
Cellosaurus(Expasy) CVCL_1759
deposit info
lot info
Medium Medium List
Culture type Adherent cells
Medium and additives RPMI1640 + 10% FBS
Antibiotics Free
Passage method 0.25% Trypsin
Culture information Passage ratio 1 : 8 split
SC frequency Subculture : 2 times/week
Temperature 37 ℃
CO2 concentration 5 %
Freeze medium Medium + 10% DMSO
Freezing method Slow freezing
Mycoplasma (-)
Isozyme LD, NP
STR(human) OK
Reference information Reference 5
User's Publication 60


To topTop
Reference
3174  Hay, Park, Gazdar, Ed.    Atlas of Human Tumor Cell Lines  1994  269-282   
3173  Nishihira T, Hashimoto Y, Katayama M, Mori S, Kuroki T  Molecular and cellular features of esophageal cancer cells.  J Cancer Res Clin Oncol  1993  119:441-9  PubMed ID: 8509434  
1016  Akaishi, T., Sekine, Y., Sanekata, K., Nishihira, T. and Kasai, M.  Characteristics of Growth and Effectiveness of Anti-Cancer Drugs on Tissue Cultured Human Esophageal Cancer Cells.  Esophageal Cancer  1986  35-38   
3172  Kuriya Y, Kitamura M, Akaishi T, Hirayama K, Sekine Y, Nishihira T, Kasai M  A new cell line (TE-3) derived from human squamous cell carcinoma of the esophagus.  Tohoku J Exp Med  1983  139:377-87  PubMed ID: 6868074   DOI: 10.1620/tjem.139.377
1015  Nishihira T, Kasai M, Mori S, Watanabe T, Kuriya Y, Suda M, Kitamura M, Hirayama K, Akaishi T, Sasaki T.  Characteristics of two cell lines (TE-1 and TE-2) derived from human squamous cell carcinoma of the esophagus.  Gan   1979  70(5):575-84  PubMed ID: 520749  

To topTop
User's Publication
20614  Tsuchihashi K, Hirata Y, Yamasaki J, Suina K, Tanoue K, Yae T, Masuda K, Baba E, Akashi K, Kitagawa Y, Saya H, Nagano O.  Presence of spontaneous epithelial-mesenchymal plasticity in esophageal cancer.  Biochem Biophys Rep  2022  30:101246  PubMed ID: 35330672   DOI: 10.1016/j.bbrep.2022.101246
20666  Li Z, Zou L, Xiao ZX, Yang J.  Transcriptome‑based drug repositioning identifies TPCA‑1 as a potential selective inhibitor of esophagus squamous carcinoma cell viability.  Int J Mol Med  2022  49(6)  PubMed ID: 35417037   DOI: 10.3892/ijmm.2022.5131
20714  Zhai Y, Shan C, Zhang H, Kong P, Zhang L, Wang Y, Hu X, Cheng X.  FAT1 downregulation enhances stemness and cisplatin resistance in esophageal squamous cell carcinoma.  Mol Cell Biochem  2022    PubMed ID: 35606602   DOI: 10.1007/s11010-022-04475-4
13104  Yoshida T, Yokobori T, Saito H, Kuriyama K, Kumakura Y, Honjo H, Hara K, Sakai M, Miyazaki T, Obinata H, Erkhem-Ochir B, Gombodorj N, Sohda M, Saeki H, Kuwano H, Shirabe K.  CD36 Expression Is Associated with Cancer Aggressiveness and Energy Source in Esophageal Squamous Cell Carcinoma.  Ann Surg Oncol  2021    PubMed ID: 32529269   DOI: 10.1245/s10434-020-08711-3
16116  Kobayashi T, Makino T, Yamashita K, Saito T, Tanaka K, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Morii E, Eguchi H, Doki Y.  APR-246 induces apoptosis and enhances chemo-sensitivity via activation of ROS and TAp73-Noxa signal in oesophageal squamous cell cancer with TP53 missense mutation  Br J Cancer  2021  125(11):1523-1532  PubMed ID: 34599296   DOI: 10.1038/s41416-021-01561-0
16743  Ogo A, Miyake S, Kubota H, Higashida M, Matsumoto H, Teramoto F, Hirai T, Ueno T.  The Mechanism of the Synergistic Anticancer Effect of CDDP and EPA in the TE1 Cell Line  Anticancer Res  2021  41(4):1771-1778  PubMed ID: 33813381   DOI: 10.21873/anticanres.14942
13092  Feng Y, Yan S, Huang Y, Huang Q, Wang F, Lei Y.  High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.  BMC Cancer  2020    PubMed ID: 32600359   DOI: 10.1186/s12885-020-07068-w
13113  Kunishige T, Migita K, Matsumoto S, Wakatsuki K, Nakade H, Miyao S, Kuniyasu H, Sho M.  Ring box protein-1 is associated with a poor prognosis and tumor progression in esophageal cancer.  Oncol Lett  2020    PubMed ID: 32782608   DOI: 10.3892/ol.2020.11840
13206  Kubota H, Hirai T, Yamauchi A, Ogo A, Matsumoto H, Ueno T.  Inhibitory Effect of Eicosapentaenoic Acid on the Migration of the Esophageal Squamous Cell Carcinoma Cell Line TE-1.  Anticancer Res  2020    PubMed ID: 32878792   DOI: 10.21873/anticanres.14507
13600  Sano H, Futamura M, Gaowa S, Kamino H, Nakamura Y, Yamaguchi K, Tanaka Y, Yasufuku I, Nakakami A, Arakawa H, Yoshida K.  p53/Mieap-regulated mitochondrial quality control plays an important role as a tumor suppressor in gastric and esophageal cancers  Biochem Biophys Res Commun  2020  529(3):582-589.  PubMed ID: 32736677   DOI: 10.1016/j.bbrc.2020.05.168
14366  Ito S, Masuda T, Noda M, Hu Q, Shimizu D, Kuroda Y, Eguchi H, Tobo T, Utsunomiya T, Mimori K.  Prognostic Significance of PD-1, PD-L1 and CD8 Gene Expression Levels in Gastric Cancer  Oncology  2020  98(7):501-511  PubMed ID: 32380498   DOI: 10.1159/000506075
14800  Ohashi S, Kikuchi O, Nakai Y, Ida T, Saito T, Kondo Y, Yamamoto Y, Mitani Y, Nguyen Vu TH, Fukuyama K, Tsukihara H, Suzuki N, Muto M.  Synthetic Lethality with Trifluridine/Tipiracil and Checkpoint Kinase 1 Inhibitor for Esophageal Squamous Cell Carcinoma  Mol Cancer Ther  2020  19(6):1363-1372  PubMed ID: 32371587   DOI: 10.1158/1535-7163.MCT-19-0918
11491  Shafaee A, Pirayesh Islamian J, Zarei D, Mohammadi M, Nejati-Koshki K, Farajollahi A, Aghamiri SMR, Rahmati Yamchi M, Baradaran B, Asghari Jafarabadi M.  Induction of Apoptosis by a Combination of 2-Deoxyglucose and Metformin in Esophageal Squamous Cell Carcinoma by Targeting Cancer Cell Metabolism.  Iran J Med Sci  2019    PubMed ID: 30936596  
11455  Miyake S, Ogo A, Kubota H, Teramoto F, Hirai T.  β-Hydroxy-β-methylbutyrate Suppresses NF-ĸB Activation and IL-6 Production in TE-1 Cancer Cells.  In Vivo  2019    PubMed ID: 30804112   DOI: 10.21873/invivo.11481
11526  Liu J, Min L, Zhu S, Guo Q, Li H, Zhang Z, Zhao Y, Xu C, Zhang S.  Cyclin-Dependent Kinase Inhibitor 3 Promoted Cell Proliferation by Driving Cell Cycle from G1 to S Phase in Esophageal Squamous Cell Carcinoma.  J Cancer  2019    PubMed ID: 31205550   DOI: 10.7150/jca.27053
11699  Kiyozumi Y, Baba Y, Okadome K, Yagi T, Ogata Y, Eto K, Hiyoshi Y, Ishimoto T, Iwatsuki M, Iwagami S, Miyamoto Y, Yoshida N, Watanabe M, Baba H.  Indoleamine 2, 3-dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancer.  Cancer Sci  2019  110(6):1863-1871  PubMed ID: 31012515   DOI: 10.1111/cas.14028
12594  Kalikawe R, Baba Y, Nomoto D, Okadome K, Miyake K, Eto K, Hiyoshi Y, Nagai Y, Iwatsuki M, Ishimoto T, Iwagami S, Miyamoto Y, Yoshida N, Watanabe M, Baba H.  Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer  Cancer Sci  2019  110(12):3727-3737  PubMed ID: 31599475   DOI: 10.1111/cas.14214
12595  Sawayama H, Ogata Y, Ishimoto T, Mima K, Hiyoshi Y, Iwatsuki M, Baba Y, Miyamoto Y, Yoshida N, Baba H.  Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer  Cancer Sci   2019  110(5):1705-1714  PubMed ID: 30861255   DOI: 10.1111/cas.13995
12596  Son SW, Chau GC, Kim ST, Um SH.  Vacuolar H +-ATPase Subunit V0C Regulates Aerobic Glycolysis of Esophageal Cancer Cells via PKM2 Signaling  Cells  2019  8(10):1137  PubMed ID: 31554233   DOI: 10.3390/cells8101137
10798  Shinno N, Kimura H, Sada R, Takiguchi S, Mori M, Fumoto K, Doki Y, Kikuchi A.  Activation of the Dickkopf1-CKAP4 pathway is associated with poor prognosis of esophageal cancer and anti-CKAP4 antibody may be a new therapeutic drug.  Oncogene  2018  37(26):3471-3484  PubMed ID: 29563607   DOI: 10.1038/s41388-018-0179-2
4355  Furukawa H, Makino T, Yamasaki M, Tanaka K, Miyazaki Y, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y.  PRIMA-1 induces p53-mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation.  Cancer Sci.  2018  109(2):412-421  PubMed ID: 29168598   DOI: 10.1111/cas.13454
4356  Ishibashi O, Akagi I, Ogawa Y, Inui T.  MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway.  Biochem Biophys Res Commun.  2018  501(2):507-513  PubMed ID: 29738771   DOI: 10.1016/j.bbrc.2018.05.025
4357  Kim MJ, Choi SK, Hong SH, Eun JW, Nam SW, Han JW, You JS.  Oncogenic IL7R is downregulated by histone deacetylase inhibitor in esophageal squamous cell carcinoma via modulation of acetylated FOXO1.  Int. J. Oncol.  2018  53(1):395-403  PubMed ID: 29749437   DOI: 10.3892/ijo.2018.4392
4504  Piao L, Yang Z, Jin J, Ni W, Qi W, Xuan Y.  B7H4 is associated with stemness and cancer progression in esophageal squamous cell carcinoma.  Hum. Pathol.  2018  80:152-162  PubMed ID: 29885401   DOI: 10.1016/j.humpath.2018.05.021
4505  Yang Z, Ni W, Cui C, Qi W, Piao L, Xuan Y.  Identification of LETM1 as a marker of cancer stem-like cells and predictor of poor prognosis in esophageal squamous cell carcinoma.  Hum. Pathol.  2018  81:148-156  PubMed ID: 30031102   DOI: 10.1016/j.humpath.2018.07.001
9448  Chihiro Kajiwara, Katsumi Fumoto, Hirokazu Kimura, Satoshi Nojima, Keita Asano, Kazuki Odagiri, Makoto Yamasaki, Hayato Hikita, Tetsuo Takehara, Yuichiro Doki, Eiichi Morii, Akira Kikuchii  p63-Dependent Dickkopf3 Expression Promotes Esophageal Cancer Cell Proliferation via CKAP4  Cancer Res  2018  78(21):6107-6120  PubMed ID: 30181180   DOI: 10.1158/0008-5472.CAN-18-1749
9998  Hijiya N, Shibata T, Daa T, Hamanaka R, Uchida T, Matsuura K, Tsukamoto Y, Nakada C, Iha H, Inomata M, Moriyama M.  Overexpression of cannabinoid receptor 1 in esophageal squamous cell carcinoma is correlated with metastasis to lymph nodes and distant organs, and poor prognosis.  Pathol. Int.  2017  67:83-90  PubMed ID: 27976824   DOI: 10.1111/pin.12495
10004  Iwaya T, Sawada G, Amano S, Kume K, Ito C, Endo F, Konosu M, Shioi Y, Akiyama Y, Takahara T, Otsuka K, Nitta H, Koeda K, Mizuno M, Nishizuka S, Sasaki A, Mimori K.  Downregulation of ST6GALNAC1 is associated with esophageal squamous cell carcinoma development.  Int. J. Oncol.  2017  50:441-447  PubMed ID: 28035351   DOI: 10.3892/ijo.2016.3817
10049  Wong M, Funasaka K, Obayashi T, Miyahara R, Hirooka Y, Hamaguchi M, Goto H, Senga T.  AMPD3 is associated with the malignant characteristics of gastrointestinal stromal tumors.  Oncol Lett  2017  13:1281-1287  PubMed ID: 28454247   DOI: 10.3892/ol.2016.5532
10116  Akagi I, Ishibashi O.  RNA-Seq analysis of human cell lines established from normal and neoplastic esophageal squamous epithelium.  Genom Data  2017  12:4-6  PubMed ID: 28224081   DOI: 10.1016/j.gdata.2017.02.002
10141  Sugase T, Takahashi T, Serada S, Nakatsuka R, Fujimoto M, Ohkawara T, Hara H, Nishigaki T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Kishimoto T, Mori M, Doki Y, Naka T.  Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.  Int. J. Cancer  2017  140:2608-2621  PubMed ID: 28233302   DOI: 10.1002/ijc.30666
10304  Sato H, Wu Y, Kato Y, Liu Q, Hirai H, Yoshizawa T, Morohashi S, Watanabe J, Kijima H.  DEC2 expression antagonizes cisplatin‑induced apoptosis in human esophageal squamous cell carcinoma.  Mol Med Rep  2017  16:43-48  PubMed ID: 28498447   DOI: 10.3892/mmr.2017.6571
10353  Kawaguchi T, Komatsu S, Ichikawa D, Hirajima S, Nishimura Y, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Otsuji E.  Overexpression of TRIM44 is related to invasive potential and malignant outcomes in esophageal squamous cell carcinoma.  Tumour Biol.  2017  39:1010428317700409  PubMed ID: 28618928   DOI: 10.1177/1010428317700409
10365  Yamamoto M, Yamasaki M, Tsukao Y, Tanaka K, Miyazaki Y, Makino T, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y.  Poly (ADP-ribose) polymerase-1 inhibition decreases proliferation through G2/M arrest in esophageal squamous cell carcinoma.  Oncol Lett  2017  14:1581-1587  PubMed ID: 28789382   DOI: 10.3892/ol.2017.6334
10449  Yoshioka M, Ohashi S, Ida T, Nakai Y, Kikuchi O, Amanuma Y, Matsubara J, Yamada A, Miyamoto S, Natsuizaka M, Nakagawa H, Chiba T, Seno H, Muto M.  Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells.  J. Exp. Clin. Cancer Res.  2017  36:101  PubMed ID: 28764725   DOI: 10.1186/s13046-017-0572-7
10977    Role of HDM2 Gene in Radio-Sensitivity of Esophageal Cancer Cell Lines to Irradiation  Int J Cancer Manag  2017  10:e8950    DOI: 10.5812/ijcm.8950
14626  Kumakura Y, Rokudai S, Iijima M, Altan B, Yoshida T, Bao H, Yokobori T, Sakai M, Sohda M, Miyazaki T, Nishiyama M, Kuwano H.  Elevated expression of ΔNp63 in advanced esophageal squamous cell carcinoma  Cancer Sci  2017  108(11):2149-2155  PubMed ID: 28892579   DOI: 10.1111/cas.13394
14646  Tanabe K, Shinsato Y, Furukawa T, Kita Y, Hatanaka K, Minami K, Kawahara K, Yamamoto M, Baba K, Mori S, Uchikado Y, Maemura K, Tanimoto A, Natsugoe S.  Filamin C promotes lymphatic invasion and lymphatic metastasis and increases cell motility by regulating Rho GTPase in esophageal squamous cell carcinoma  Oncotarget  2017  8(4):6353-6363  PubMed ID: 28031525   DOI: 10.18632/oncotarget.14087
14654  Hadisaputri YE, Miyazaki T, Yokobori T, Sohda M, Sakai M, Ozawa D, Hara K, Honjo H, Kumakura Y, Kuwano H.  TNFAIP3 overexpression is an independent factor for poor survival in esophageal squamous cell carcinoma  Int J Oncol  2017  50(3):1002-1010  PubMed ID: 28197630   DOI: 10.3892/ijo.2017.3869
14743  Osako Y, Seki N, Koshizuka K, Okato A, Idichi T, Arai T, Omoto I, Sasaki K, Uchikado Y, Kita Y, Kurahara H, Maemura K, Natsugoe S.  Regulation of SPOCK1 by dual strands of pre-miR-150 inhibit cancer cell migration and invasion in esophageal squamous cell carcinoma  J Hum Genet  2017  62(11):935-944  PubMed ID: 28659612   DOI: 10.1038/jhg.2017.69
9724  Hara H, Takahashi T, Serada S, Fujimoto M, Ohkawara T, Nakatsuka R, Harada E, Nishigaki T, Takahashi Y, Nojima S, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Miyata H, Nakajima K, Takiguchi S, Morii E, Mori M, Doki Y, Naka T.  Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma.  Br. J. Cancer  2016  115:66-75  PubMed ID: 27310703   DOI: 10.1038/bjc.2016.183
9883  Schlierf A, Altmann E, Quancard J, Jefferson AB, Assenberg R, Renatus M, Jones M, Hassiepen U, Schaefer M, Kiffe M, Weiss A, Wiesmann C, Sedrani R, Eder J, Martoglio B.  Targeted inhibition of the COP9 signalosome for treatment of cancer.  Nat Commun  2016  7:13166  PubMed ID: 27774986   DOI: 10.1038/ncomms13166
10881    RGD conjugated, Cy5.5 labeled polyamidoamine dendrimers for targeted near-infrared fluorescence imaging of esophageal squamous cell carcinoma  RSC Adv.  2016  6, 74560-74566    DOI: 10.1039/C6RA12927G
12618  Kosumi K, Baba Y, Sakamoto A, Ishimoto T, Harada K, Nakamura K, Kurashige J, Hiyoshi Y, Iwatsuki M, Iwagami S, Sakamoto Y, Miyamoto Y, Yoshida N, Oki E, Watanabe M, Hino S, Nakao M, Baba H.  Lysine-specific demethylase-1 contributes to malignant behavior by regulation of invasive activity and metabolic shift in esophageal cancer  Int J Cancer  2016  138(2):428-39  PubMed ID: 26240060   DOI: 10.1002/ijc.29714
12663  Song IH, Lee TS, Park YS, Lee JS, Lee BC, Moon BS, An GI, Lee HW, Kim KI, Lee YJ, Kang JH, Lim SM.  Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model  J Nucl Med  2016  57(7):1105-11  PubMed ID: 26917708   DOI: 10.2967/jnumed.115.167155
12969  Hamada J, Shoda K, Masuda K, Fujita Y, Naruto T, Kohmoto T, Miyakami Y, Watanabe M, Kudo Y, Fujiwara H, Ichikawa D, Otsuji E, Imoto I.  Tumor-promoting function and prognostic significance of the RNA-binding protein T-cell intracellular antigen-1 in esophageal squamous cell carcinoma  Oncotarget  2016  7(13):17111-28  PubMed ID: 26958940   DOI: 10.18632/oncotarget.7937
13992  Nakamura K, Baba Y, Kosumi K, Harada K, Shigaki H, Miyake K, Kiyozumi Y, Ohuchi M, Kurashige J, Ishimoto T, Iwatsuki M, Sakamoto Y, Yoshida N, Watanabe M, Nakao M, Baba H.  UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma  Oncotarget  2016  7(36):57821-5783  PubMed ID: 27507047   DOI: 10.18632/oncotarget.11067
13993  Pirayesh Islamian J, Mohammadi M, Baradaran B, Farajollahi A, Aghamiri SM, Asghari Jafarabadi M, Karami H, Monfaredan A, Shanehbandi D.  Enhancing radiosensitivity of TE1, TE8, and TE 11 esophageal squamous carcinoma cell lines by Hdm2-siRNA targeted gene therapy in vitro  Bioimpacts  2016  6(2):93-8  PubMed ID: 27525226   DOI: 10.15171/bi.2016.13
14119  Park M, Yoon HJ, Kang MC, Kwon J, Lee HW.  PTK7 regulates radioresistance through nuclear factor-kappa B in esophageal squamous cell carcinoma  Tumour Biol  2016  37(10):14217-14224  PubMed ID: 27557627   DOI: 10.1007/s13277-016-5288-3
7350  Nabeki B, Ishigami S, Uchikado Y, Sasaki K, Kita Y, Okumura H, Arigami T, Kijima Y, Kurahara H, Maemura K, Natsugoe S.  Interleukin-32 expression and Treg infiltration in esophageal squamous cell carcinoma.  Anticancer Res.  2015  35:2941-7  PubMed ID: 25964580  
7382  Saito S, Morishima K, Ui T, Hoshino H, Matsubara D, Ishikawa S, Aburatani H, Fukayama M, Hosoya Y, Sata N, Lefor AK, Yasuda Y, Niki T.  The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma.  BMC Cancer  2015  15:82  PubMed ID: 25884729   DOI: 10.1186/s12885-015-1065-8
15151  Yokobori T, Bao P, Fukuchi M, Altan B, Ozawa D, Rokudai S, Bai T, Kumakura Y, Honjo H, Hara K, Sakai M, Sohda M, Miyazaki T, Ide M, Nishiyama M, Oyama T, Kuwano H.  Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1α Expression and Cancer Progression in Esophageal Squamous Cell Carcinoma  Ann Surg Oncol  2015  22 Suppl 3:S1566-73  PubMed ID: 26310281   DOI: 10.1245/s10434-015-4831-6
15184  Harada K, Baba Y, Ishimoto T, Kosumi K, Tokunaga R, Izumi D, Ohuchi M, Nakamura K, Kiyozumi Y, Kurashige J, Iwagami S, Miyamoto Y, Sakamoto Y, Yoshida N, Oki E, Watanabe M, Baba H.  Suppressor microRNA-145 Is Epigenetically Regulated by Promoter Hypermethylation in Esophageal Squamous Cell Carcinom  Anticancer Res  2015  35(9):4617-24  PubMed ID: 26254350  
13765  Sawayama H, Ishimoto T, Watanabe M, Yoshida N, Sugihara H, Kurashige J, Hirashima K, Iwatsuki M, Baba Y, Oki E, Morita M, Shiose Y, Baba H.  Small molecule agonists of PPAR-γ exert therapeutic effects in esophageal cancer  Cancer Res  2014  74(2):575-85  PubMed ID: 24272485   DOI: 10.1158/0008-5472.CAN-13-1836
15825  Inhibition of mitogen-activated protein kinase pathway can induce upregulation of human leukocyte antigen class I without PD-L1-upregulation in contrast to interferon-γ treatment  Inhibition of mitogen-activated protein kinase pathway can induce upregulation of human leukocyte antigen class I without PD-L1-upregulation in contrast to interferon-γ treatment  Cancer Sci  2014  105(10):1236-44  PubMed ID: 25154680   DOI: 10.1111/cas.12503
17132  Ichiro Akagi, Osamu Ishibashi, Takeshi Matsutani, Nobutoshi Hagiwara, Akihisa Matsuda, Tsutomu Nomura, Hiroshi Makino, Hiroshi Yoshida, Masao Miyashita, Eiji Uchida  Comprehensive Analysis of MicroRNA and mRNA Expression in Normal and Tumorous Human Esophageal Squamous Cell Lines Using Microarray Datasets  Dataset Papers in Science  2014  1-3:2014-12-15    DOI: 10.1155/2014/376541
17149  Yeo SY, Ha SY, Yu EJ, Lee KW, Kim JH, Kim SH.  ZNF282 (Zinc finger protein 282), a novel E2F1 co-activator, pr  Oncotarget  2014  5(23):12260-72  PubMed ID: 25373738   DOI: 10.18632/oncotarget.2630
16294  Britschgi A, Bill A, Brinkhaus H, Rothwell C, Clay I, Duss S, Rebhan M, Raman P, Guy CT, Wetzel K, George E, Popa MO, Lilley S, Choudhury H, Gosling M, Wang L, Fitzgerald S, Borawski J, Baffoe J, Labow M, Gaither LA, Bentires-Alj M.  Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling  Proc Natl Acad Sci U S A  2013  110(11):E1026-34  PubMed ID: 23431153   DOI: 10.1073/pnas.1217072110
8430  Ooki A, Yamashita K, Kikuchi S, Sakuramoto S, Katada N, Watanabe M.  Phosphatase of regenerating liver-3 as a convergent therapeutic target for lymph node metastasis in esophageal squamous cell carcinoma.  Int. J. Cancer  2010  127:543-54  PubMed ID: 19960436   DOI: 10.1002/ijc.25082
6410  Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.  Is parainfluenza virus a threatening virus for human cancer cell lines?  Hum Cell  2009  22(3):81-4  PubMed ID: 19624309   DOI: 10.1111/j.1749-0774.2009.00071.x



Back Back Return Top Page